title: Diabetes caused by Kir6.2 mutation: successful treatment with oral glibenclamide switched from continuous subcutaneous insulin infusion in the early phase of the disease.
authors.affiliation: Department of Pediatrics, Nihon University School of Medicine, Tokyo, Kyoto, Japan.
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Nagano
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Urakami
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Mine
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Watanabe
authors.forename: Ayako
authors.initials: A
authors.lastname: Yoshida
authors.forename: Junichi
authors.initials: J
authors.lastname: Suzuki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Saito
authors.forename: Mika
authors.initials: M
authors.lastname: Ishige
authors.forename: Shori
authors.initials: S
authors.lastname: Takahashi
authors.forename: Hideo
authors.initials: H
authors.lastname: Mugishima
authors.forename: Tohru
authors.initials: T
authors.lastname: Yorifuji
mesh_terms: D000284:Administration, Oral; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000235:genetics*; D005905:Glyburide / Q000008:administration & dosage*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007231:Infant, Newborn; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D008297:Male; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D000099161:Kcnj11 Channel
chemical_list: D005905:Glyburide; D007004:Hypoglycemic Agents; D007328:Insulin; D024661:Potassium Channels, Inwardly Rectifying; D000099161:Kcnj11 Channel